首页> Vaccine: X> Safety and antibody responses of Omicron BA.4/5 bivalent booster vaccine among hybrid immunity with diverse vaccination histories: A cohort study.

Safety and antibody responses of Omicron BA.4/5 bivalent booster vaccine among hybrid immunity with diverse vaccination histories: A cohort study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sitthichai,Kanokudom

第一单位： Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.;Center of Excellence in Osteoarthritis and Musculoskeleton, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand.

作者： Sitthichai,Kanokudom ^[1] ; Jira,Chansaenroj ^[2] ; Nungruthai,Suntronwong ^[2] ; Lakkhana,Wongsrisang ^[2] ; Ratchadawan,Aeemjinda ^[2] ; Preeyaporn,Vichaiwattana ^[2] ; Thaksaporn,Thatsanathorn ^[2] ; Warangkana,Chantima ^[3] ; Pattarakul,Pakchotanon ^[4] ; Thaneeya,Duangchinda ^[4] ; Natthinee,Sudhinaraset ^[2] ; Sittisak,Honsawek ^[5] ; Yong,Poovorawan ^[6]

作者单位： Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.;Center of Excellence in Osteoarthritis and Musculoskeleton, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand. ^[1] Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand. ^[2] Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.;Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. ^[3] Molecular Biology of Dengue and Flaviviruses Research Team, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand. ^[4] Center of Excellence in Osteoarthritis and Musculoskeleton, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand. ^[5] Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.;Fellow of the Royal Society of Thailand (FRS [T]), The Royal Society of Thailand, Sanam Sueapa, Dusit, Bangkok 10300, Thailand. ^[6]

关键词 BA.4/5 bivalent mRNA vaccine Booster dose Coronavirus diseases-19 (COVID-19)Robust neutralizing antibodies Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)mRNA-1273.222

DOI 10.1016/j.jvacx.2024.100538

PMID 39211731

发布时间 2024-09-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Vaccine

2024年20卷

100538页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Vaccine

2024年20卷

100538页

检索历史清除

Safety and antibody responses of Omicron BA.4/5 bivalent booster vaccine among hybrid immunity with diverse vaccination histories: A cohort study.

Vaccine

相似文献

同项目论文

Vaccine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and antibody responses of Omicron BA.4/5 bivalent booster vaccine among hybrid immunity with diverse vaccination histories: A cohort study.

Vaccine

相似文献

同项目论文

Vaccine

相关期刊

检索历史清除